Initial Treatment for Hypertension with High Pulse Pressure

Understanding High Pulse Pressure and Initial Pharmacological Approach

• The European Heart Journal recommends initiating treatment with a calcium channel blocker (CCB) or thiazide/thiazide-like diuretic as first-line therapy, combined with aggressive lifestyle modifications, targeting a blood pressure <130/80 mmHg for patients with hypertension and high pulse pressure 1
• For non-Black patients, the European Heart Journal suggests starting with a low-dose ACE inhibitor or ARB, and if blood pressure remains uncontrolled, adding a dihydropyridine CCB or thiazide-like diuretic 1
• For Black patients, the European Heart Journal recommends beginning with a low-dose ARB plus dihydropyridine CCB, or alternatively a CCB plus thiazide-like diuretic, as this combination is more effective than monotherapy in this population 1

Blood Pressure Targets and Timeline

• The American College of Cardiology, as referenced in Praxis Medical Insights, recommends a target BP of <130/80 mmHg for most adults, with an initial goal of reducing BP by at least 20/10 mmHg 2
• The European Heart Journal and Praxis Medical Insights suggest achieving target blood pressure within 3 months of initiating treatment 1, 2, 3

Monitoring Strategy

• Praxis Medical Insights recommends scheduling follow-up within 2-4 weeks to assess treatment response and medication tolerability, and implementing home BP monitoring to track progress and improve adherence 2
• The guideline also suggests confirming BP readings with multiple measurements using validated devices with appropriate cuff size 2, 3

When to Escalate Therapy

• The European Heart Journal recommends adding a second agent from a different class (CCB, thiazide diuretic, or RAS blocker) if BP remains ≥140/90 mmHg after 3 months despite initial therapy 1
• Praxis Medical Insights suggests referring to a hypertension specialist if BP remains uncontrolled on 3 medications 2